{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:24:05Z","timestamp":1791397445885,"version":"4.3.3"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["R01-CA58853"],"award-info":[{"award-number":["R01-CA58853"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["R01-CA66519"],"award-info":[{"award-number":["R01-CA66519"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["R01-CA174462"],"award-info":[{"award-number":["R01-CA174462"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["P01-CA22443"],"award-info":[{"award-number":["P01-CA22443"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["P30-CA14520"],"award-info":[{"award-number":["P30-CA14520"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.semcancer.2014.01.002","type":"journal-article","created":{"date-parts":[[2014,1,20]],"date-time":"2014-01-20T16:46:29Z","timestamp":1390236389000},"page":"60-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":283,"special_numbering":"C","title":["Regulation of the latent-lytic switch in Epstein\u2013Barr virus"],"prefix":"10.1016","volume":"26","author":[{"given":"Shannon C.","family":"Kenney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet E.","family":"Mertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2014.01.002_bib0005","series-title":"Fields Virol.","first-page":"2655","article-title":"Epstein\u2013Barr virus","author":"Rickinson","year":"2006"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0010","series-title":"Fields Virology","first-page":"2603","article-title":"Epstein\u2013Barr virus and its replication","author":"Kieff","year":"2006"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0015","doi-asserted-by":"crossref","first-page":"13993","DOI":"10.1128\/JVI.79.22.13993-14003.2005","article-title":"Epstein\u2013Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model","volume":"79","author":"Hong","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0020","doi-asserted-by":"crossref","first-page":"13984","DOI":"10.1128\/JVI.79.22.13984-13992.2005","article-title":"Epstein\u2013Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell lines","volume":"79","author":"Hong","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0025","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/JVI.01512-10","article-title":"A new model of Epstein\u2013Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas","volume":"85","author":"Ma","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0030","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1006\/viro.1993.1397","article-title":"Epstein\u2013Barr virus gene expression in oral hairy leukoplakia","volume":"195","author":"Lau","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0035","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1086\/426823","article-title":"Epstein\u2013Barr virus (EBV) infection in epithelial cells in vivo: rare detection of EBV replication in tongue mucosa but not in salivary glands","volume":"191","author":"Frangou","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0040","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1128\/JVI.79.2.1296-1307.2005","article-title":"Terminal differentiation into plasma cells initiates the replicative cycle of Epstein\u2013Barr virus in vivo","volume":"79","author":"Laichalk","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0045","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1128\/JVI.63.1.445-449.1989","article-title":"Synchronous and sequential activation of latently infected Epstein\u2013Barr virus genomes","volume":"63","author":"Takada","year":"1989","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0050","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jcv.2006.06.013","article-title":"Hypoxia can contribute to the induction of the Epstein\u2013Barr virus (EBV) lytic cycle","volume":"37","author":"Jiang","year":"2006","journal-title":"J Clin Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0055","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/ijc.2910570623","article-title":"Endogenous TGF-\u03b2 contributes to the induction of the EBV lytic cycle in two burkitt lymphoma cell lines","volume":"57","author":"Di Renzo","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0060","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1128\/JVI.74.13.5810-5818.2000","article-title":"Transforming growth factor beta 1 stimulates expression of the Epstein\u2013Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway","volume":"74","author":"Fahmi","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0065","doi-asserted-by":"crossref","first-page":"7836","DOI":"10.1128\/JVI.01197-10","article-title":"Transforming growth factor \u03b2-induced reactivation of Epstein\u2013Barr virus involves multiple Smad-binding elements cooperatively activating expression of the latent-lytic switch BZLF1 gene","volume":"85","author":"Iempridee","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0070","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0966-842X(97)01129-3","article-title":"Reactivation of Epstein\u2013Barr virus: regulation and function of the BZLF1 gene","volume":"5","author":"Speck","year":"1997","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0075","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1038\/sj.onc.1206548","article-title":"Virally targeted therapies for EBV-associated malignancies","volume":"22","author":"Israel","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0080","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/rmv.456","article-title":"Reactivation of Epstein\u2013Barr virus from latency","volume":"15","author":"Amon","year":"2005","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0085","first-page":"55","article-title":"Woodward Award: development of novel, EBV-targeted therapies for EBV-positive tumors","volume":"117","author":"Kenney","year":"2006","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0090","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.chom.2010.06.014","article-title":"Viral latency and its regulation: lessons from the \u03b3-herpesviruses","volume":"8","author":"Speck","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0095","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.canlet.2010.08.018","article-title":"miRNAs in the pathogenesis of oncogenic human viruses","volume":"305","author":"Lin","year":"2011","journal-title":"Cancer Lett"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0100","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.micinf.2011.07.007","article-title":"The role of microRNAs in Epstein\u2013Barr virus latency and lytic reactivation","volume":"13","author":"Forte","year":"2011","journal-title":"Microbes Infect Inst Pasteur"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2013.05.013","article-title":"\u03b3-Herpesvirus-encoded miRNAs and their roles in viral biology and pathogenesis","volume":"3","author":"Zhu","year":"2013","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0110","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.coviro.2013.03.004","article-title":"Epigenetic regulation of EBV and KSHV latency","volume":"3","author":"Chen","year":"2013","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0115","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.molcel.2006.01.006","article-title":"Structural basis of lytic cycle activation by the Epstein\u2013Barr virus ZEBRA protein","volume":"21","author":"Petosa","year":"2006","journal-title":"Mol Cell"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0120","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1093\/emboj\/19.12.3080","article-title":"The Epstein\u2013Barr virus lytic program is controlled by the co-operative functions of two transactivators","volume":"19","author":"Feederle","year":"2000","journal-title":"EMBO J"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0125","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1128\/JVI.01790-12","article-title":"Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein\u2013Barr virus lytic gene expression and viral replication","volume":"87","author":"Wille","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0130","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1128\/JVI.02445-06","article-title":"Phosphoacceptor site S173 in the regulatory domain of Epstein\u2013Barr virus ZEBRA protein is required for lytic DNA replication but not for activation of viral early genes","volume":"81","author":"El-Guindy","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0135","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1128\/JVI.06760-11","article-title":"Genome-wide analysis of Epstein\u2013Barr virus Rta DNA binding","volume":"86","author":"Heilmann","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0140","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1128\/JVI.74.3.1224-1233.2000","article-title":"Epstein\u2013Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases","volume":"74","author":"Adamson","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0145","doi-asserted-by":"crossref","first-page":"6135","DOI":"10.1128\/JVI.75.13.6135-6142.2001","article-title":"Epstein\u2013Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation","volume":"75","author":"Darr","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0150","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1128\/JVI.75.11.5240-5251.2001","article-title":"Autostimulation of the Epstein\u2013Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites","volume":"75","author":"Ragoczy","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0155","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1093\/nar\/gki956","article-title":"Activation of Sp1-mediated transcription by Rta of Epstein\u2013Barr virus via an interaction with MCAF1","volume":"33","author":"Chang","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0160","doi-asserted-by":"crossref","first-page":"8940","DOI":"10.1128\/JVI.00569-11","article-title":"Cellular transcription factor Oct-1 interacts with the Epstein\u2013Barr virus BRLF1 protein to promote disruption of viral latency","volume":"85","author":"Robinson","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0165","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1128\/JVI.78.10.4983-4992.2004","article-title":"The BRRF1 early gene of Epstein\u2013Barr virus encodes a transcription factor that enhances induction of lytic infection by BRLF1","volume":"78","author":"Hong","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0170","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1128\/JVI.01856-10","article-title":"The Epstein\u2013Barr virus BRRF1 protein, Na, induces lytic infection in a TRAF2- and p53-dependent manner","volume":"85","author":"Hagemeier","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0175","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1128\/JVI.00315-08","article-title":"The Epstein\u2013Barr virus LF2 protein inhibits viral replication","volume":"82","author":"Calderwood","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0180","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/emboj\/16.1.143","article-title":"Cyclosporin A-sensitive induction of the Epstein\u2013Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member","volume":"16","author":"Liu","year":"1997","journal-title":"EMBO J"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0185","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/embo-reports\/kvf031","article-title":"MEF2-mediated recruitment of class II HDAC at the EBV immediate early gene BZLF1 links latency and chromatin remodeling","volume":"3","author":"Gruffat","year":"2002","journal-title":"EMBO Rep"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0190","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1128\/JVI.77.1.199-207.2003","article-title":"ZEB negatively regulates the lytic-switch BZLF1 gene promoter of Epstein\u2013Barr virus","volume":"77","author":"Kraus","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0195","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1371\/journal.ppat.0030194","article-title":"ZEB1 regulates the latent-lytic switch in infection by Epstein\u2013Barr virus","volume":"3","author":"Yu","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0200","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1128\/JVI.02706-09","article-title":"Either ZEB1 or ZEB2\/SIP1 can play a central role in regulating the Epstein\u2013Barr virus latent-lytic switch in a cell-type-specific manner","volume":"84","author":"Ellis","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0205","doi-asserted-by":"crossref","first-page":"8086","DOI":"10.1128\/JVI.00234-12","article-title":"Shutoff of BZLF1 gene expression is necessary for immortalization of primary B cells by Epstein\u2013Barr virus","volume":"86","author":"Yu","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0210","doi-asserted-by":"crossref","first-page":"10113","DOI":"10.1128\/JVI.00692-07","article-title":"ZEB1 and c-Jun levels contribute to the establishment of highly lytic Epstein\u2013Barr virus infection in gastric AGS cells","volume":"81","author":"Feng","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0215","doi-asserted-by":"crossref","first-page":"10329","DOI":"10.1128\/JVI.00923-10","article-title":"Cellular microRNAs 200b and 429 regulate the Epstein\u2013Barr virus switch between latency and lytic replication","volume":"84","author":"Ellis-Connell","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0220","doi-asserted-by":"crossref","first-page":"7892","DOI":"10.1128\/JVI.00379-10","article-title":"Differential expression of the miR-200 family microRNAs in epithelial and B cells and regulation of Epstein\u2013Barr virus reactivation by the miR-200 family member miR-429","volume":"84","author":"Lin","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0225","doi-asserted-by":"crossref","first-page":"e1002484","DOI":"10.1371\/journal.ppat.1002484","article-title":"The viral and cellular microRNA targetome in lymphoblastoid cell lines","volume":"8","author":"Skalsky","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0230","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1038\/emboj.2012.63","article-title":"EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency","volume":"31","author":"Riley","year":"2012","journal-title":"EMBO J"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0235","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1093\/emboj\/cdg226","article-title":"Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins","volume":"22","author":"Postigo","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0240","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1099\/vir.0.18740-0","article-title":"The BZLF1 promoter of Epstein\u2013Barr virus is controlled by E box-\/HI-motif-binding factors during virus latency","volume":"84","author":"Thomas","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0245","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.1128\/JVI.02615-10","article-title":"The ZIIR element of the Epstein\u2013Barr virus BZLF1 promoter plays a central role in establishment and maintenance of viral latency","volume":"85","author":"Yu","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0250","doi-asserted-by":"crossref","first-page":"7976","DOI":"10.1128\/JVI.00770-12","article-title":"An Epstein\u2013Barr virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model","volume":"86","author":"Ma","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0255","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1128\/JVI.71.4.3268-3274.1997","article-title":"The cellular YY1 transcription factor binds a cis-acting, negatively regulating element in the Epstein\u2013Barr virus BRLF1 promoter","volume":"71","author":"Zalani","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0260","unstructured":"Reusch JR, Nawandar DM, Kenney SC, Mertz JE. Unpublished data. n.d."},{"key":"10.1016\/j.semcancer.2014.01.002_bib0265","unstructured":"Nawandar DM, Kenney SC. Unpublished data. n.d."},{"key":"10.1016\/j.semcancer.2014.01.002_bib0270","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1038\/sj.onc.1203656","article-title":"High level expression of \u0394N-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?","volume":"19","author":"Crook","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0275","doi-asserted-by":"crossref","first-page":"E3473","DOI":"10.1073\/pnas.1202637109","article-title":"Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells","volume":"109","author":"Tsang","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0280","doi-asserted-by":"crossref","first-page":"e1002516","DOI":"10.1371\/journal.ppat.1002516","article-title":"The B-cell specific transcription factor, Oct-2, promotes Epstein\u2013Barr virus latency by inhibiting the viral immediate-early protein, BZLF1","volume":"8","author":"Robinson","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0285","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00546-13","article-title":"The B-cell specific transcription factor and master regulator, Pax5, promotes EBV latency by negatively regulating the viral immediate early protein, BZLF1","author":"Raver","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0290","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.virol.2010.01.002","article-title":"Cellular factors associated with latency and spontaneous Epstein\u2013Barr virus reactivation in B-lymphoblastoid cell lines","volume":"400","author":"Davies","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0295","unstructured":"Iempridee T, Reusch JR, Riching A, Johannsen E, Dovat S, Kenney SC, et al. submitted. n.d."},{"key":"10.1016\/j.semcancer.2014.01.002_bib0300","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1128\/JVI.02369-09","article-title":"Sumoylation of the Epstein\u2013Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase","volume":"84","author":"Hagemeier","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0305","doi-asserted-by":"crossref","first-page":"10290","DOI":"10.1128\/JVI.76.20.10290-10298.2002","article-title":"Signal transduction and transcription factor modification during reactivation of Epstein\u2013Barr virus from latency","volume":"76","author":"Bryant","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0310","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.antiviral.2012.09.021","article-title":"Protein kinase inhibitors that inhibit induction of lytic program and replication of Epstein\u2013Barr virus","volume":"96","author":"Goswami","year":"2012","journal-title":"Antiviral Res"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0315","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1128\/MCB.26.4.1569-1577.2006","article-title":"Essential role for protein kinase D family kinases in the regulation of class II histone deacetylases in B lymphocytes","volume":"26","author":"Matthews","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0320","doi-asserted-by":"crossref","first-page":"13566","DOI":"10.1128\/JVI.01055-07","article-title":"Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein\u2013Barr virus BZLF1 promoter","volume":"81","author":"Sun","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0325","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.1182\/blood-2011-01-332379","article-title":"Bortezomib induction of C\/EBP\u03b2 mediates Epstein\u2013Barr virus lytic activation in Burkitt lymphoma","volume":"117","author":"Shirley","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0330","doi-asserted-by":"crossref","first-page":"23345","DOI":"10.1074\/jbc.M107420200","article-title":"Epstein\u2013Barr virus BZLF1 gene is activated by transforming growth factor-\u03b2 through cooperativity of Smads and c-Jun\/c-Fos proteins","volume":"277","author":"Liang","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0335","doi-asserted-by":"crossref","first-page":"6502","DOI":"10.1128\/JVI.02560-10","article-title":"NF-\u03baB-mediated modulation of inducible nitric oxide synthase activity controls induction of the Epstein\u2013Barr virus productive cycle by transforming growth factor beta 1","volume":"85","author":"Oussaief","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0340","doi-asserted-by":"crossref","first-page":"12405","DOI":"10.1128\/JVI.01415-10","article-title":"Cellular immediate-early gene expression occurs kinetically upstream of Epstein\u2013Barr virus BZLF1 and BRLF1 following cross-linking of the B cell antigen receptor in the Akata Burkitt lymphoma cell line","volume":"84","author":"Ye","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0345","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1128\/JVI.69.6.3816-3823.1995","article-title":"The Zif268 cellular transcription factor activates expression of the Epstein\u2013Barr virus immediate-early BRLF1 promoter","volume":"69","author":"Zalani","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0350","doi-asserted-by":"crossref","DOI":"10.1002\/path.4198","article-title":"Suppression Of The LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle","author":"Vockerodt","year":"2013","journal-title":"J Pathol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0355","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1016\/S0024-3205(03)00230-3","article-title":"The EGR-1 gene is induced by DNA-damaging agents and non-genotoxic drugs in both normal and neoplastic human cells","volume":"72","author":"Qui\u00f1ones","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0360","doi-asserted-by":"crossref","first-page":"7748","DOI":"10.1128\/JVI.02608-05","article-title":"Induction of the early growth response 1 gene by Epstein\u2013Barr virus lytic transactivator Zta","volume":"80","author":"Chang","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0365","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1099\/vir.0.007922-0","article-title":"The Epstein\u2013Barr virus lytic cycle activator Zta interacts with methylated ZRE in the promoter of host target gene EGR1","volume":"90","author":"Heather","year":"2009","journal-title":"J Gen Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0370","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1128\/JVI.78.4.1893-1902.2004","article-title":"Lytic induction therapy for Epstein\u2013Barr virus-positive B-cell lymphomas","volume":"78","author":"Feng","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0375","unstructured":"Kraus RJ, Yu X, Sathiamoorthi S, Ruegsegger N, Nawandar DM, Kenney SC, et al. Unpublished data. n.d."},{"key":"10.1016\/j.semcancer.2014.01.002_bib0380","doi-asserted-by":"crossref","first-page":"13360","DOI":"10.1128\/JVI.01850-12","article-title":"The cellular ataxia telangiectasia-mutated kinase promotes Epstein\u2013Barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuli","volume":"86","author":"Hagemeier","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0385","doi-asserted-by":"crossref","first-page":"7745","DOI":"10.1128\/JVI.02717-07","article-title":"Critical role of p53 in histone deacetylase inhibitor-induced Epstein\u2013Barr virus Zta expression","volume":"82","author":"Chang","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0390","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/sj.cdd.4402029","article-title":"A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells","volume":"14","author":"Yu","year":"2006","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0395","doi-asserted-by":"crossref","first-page":"7363","DOI":"10.1128\/JVI.00154-07","article-title":"X-box-binding protein 1 activates lytic Epstein\u2013Barr virus gene expression in combination with protein kinase D","volume":"81","author":"Bhende","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0400","unstructured":"Bhende PM, Kenney SC. Unpublished data. n.d."},{"key":"10.1016\/j.semcancer.2014.01.002_bib0405","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1099\/vir.0.038661-0","article-title":"Lytic Epstein\u2013Barr virus infection in epithelial cells but not in B-lymphocytes is dependent on Blimp1","volume":"93","author":"Buettner","year":"2012","journal-title":"J Gen Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0410","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1182\/blood-2010-09-307710","article-title":"Down-regulation of BLIMP1\u03b1 by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas","volume":"117","author":"Vrzalikova","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0415","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.oraloncology.2012.03.017","article-title":"Oral dysplasia and squamous cell carcinoma: correlation between increased expression of CD21, Epstein\u2013Barr virus and CK19","volume":"48","author":"Jiang","year":"2012","journal-title":"Oral Oncol"},{"issue":"Pt 4","key":"10.1016\/j.semcancer.2014.01.002_bib0420","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1099\/0022-1317-76-4-759","article-title":"Identification of an epithelial cell differentiation responsive region within the BZLF1 promoter of the Epstein\u2013Barr virus","volume":"76","author":"Karimi","year":"1995","journal-title":"J Gen Virol"},{"issue":"Pt 6","key":"10.1016\/j.semcancer.2014.01.002_bib0425","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1099\/0022-1317-80-6-1501","article-title":"Definition of the transcription factors which bind the differentiation responsive element of the Epstein\u2013Barr virus BZLF1 Z promoter in human epithelial cells","volume":"80","author":"MacCallum","year":"1999","journal-title":"J Gen Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0430","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/ng1424","article-title":"The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome","volume":"36","author":"Bhende","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0435","doi-asserted-by":"crossref","first-page":"7338","DOI":"10.1128\/JVI.79.12.7338-7348.2005","article-title":"BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186","volume":"79","author":"Bhende","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0440","doi-asserted-by":"crossref","first-page":"e1001114","DOI":"10.1371\/journal.ppat.1001114","article-title":"CpG-methylation regulates a class of Epstein\u2013Barr virus promoters","volume":"6","author":"Bergbauer","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0445","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1073\/pnas.0911948107","article-title":"AP-1 homolog BZLF1 of Epstein\u2013Barr virus has two essential functions dependent on the epigenetic state of the viral genome","volume":"107","author":"Kalla","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0450","doi-asserted-by":"crossref","first-page":"12494","DOI":"10.1128\/JVI.01705-12","article-title":"Genome-wide analyses of Zta binding to the Epstein\u2013Barr virus genome reveals interactions in both early and late lytic cycles and an epigenetic switch leading to an altered binding profile","volume":"86","author":"Ramasubramanyan","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0455","doi-asserted-by":"crossref","first-page":"8176","DOI":"10.1073\/pnas.1301577110","article-title":"Latency of Epstein\u2013Barr virus is disrupted by gain-of-function mutant cellular AP-1 proteins that preferentially bind methylated DNA","volume":"110","author":"Yu","year":"2013","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0460","doi-asserted-by":"crossref","first-page":"9194","DOI":"10.1073\/pnas.93.17.9194","article-title":"Epstein\u2013Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism","volume":"93","author":"Zalani","year":"1996","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0465","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1128\/JVI.02487-09","article-title":"The Epstein\u2013Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production","volume":"84","author":"Meng","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0470","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/nm.1864","article-title":"Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors","volume":"14","author":"Fu","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0475","first-page":"5781","article-title":"Activation of lytic Epstein\u2013Barr Virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies","volume":"60","author":"Westphal","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0480","doi-asserted-by":"crossref","first-page":"8762","DOI":"10.1158\/0008-5472.CAN-06-1006","article-title":"Valproic acid enhances the efficacy of chemotherapy in EBV-positive tumors by increasing lytic viral gene expression","volume":"66","author":"Feng","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0485","first-page":"965","article-title":"Experimental treatment of Epstein\u2013Barr virus-associated primary central nervous system lymphoma","volume":"63","author":"Roychowdhury","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0490","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1128\/JVI.74.2.710-720.2000","article-title":"Histone acetylation and reactivation of Epstein\u2013Barr virus from latency","volume":"74","author":"Jenkins","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0495","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3858\/emm.2010.42.3.020","article-title":"ATM modulates transcription in response to histone deacetylase inhibition as part of its DNA damage response","volume":"42","author":"Jang","year":"2010","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0500","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1128\/JVI.02659-10","article-title":"Valproic acid antagonizes the capacity of other histone deacetylase inhibitors to activate the Epstein\u2013Barr virus lytic cycle","volume":"85","author":"Daigle","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0505","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1182\/blood-2006-01-024703","article-title":"A phase 1\/2 trial of arginine butyrate and ganciclovir in patients with Epstein\u2013Barr virus-associated lymphoid malignancies","volume":"109","author":"Perrine","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0510","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1200\/JCO.2009.22.1291","article-title":"Histone deacetylase inhibitors in cancer therapy","volume":"27","author":"Lane","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0515","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1158\/1078-0432.CCR-12-0574","article-title":"Cytolytic virus activation therapy for Epstein\u2013Barr virus-driven tumors","volume":"18","author":"Wildeman","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.semcancer.2014.01.002_bib0520","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1158\/1078-0432.CCR-09-2424","article-title":"Viral response to chemotherapy in endemic Burkitt lymphoma","volume":"16","author":"Tang","year":"2010","journal-title":"Clin Cancer Res"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X14000091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X14000091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T10:27:06Z","timestamp":1597400826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X14000091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":104,"alternative-id":["S1044579X14000091"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2014.01.002","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation of the latent-lytic switch in Epstein\u2013Barr virus","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2014.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}